Factors influencing the lipid response to selective alpha 1-inhibition.
作者信息
Dzau V J
机构信息
Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115.
出版信息
J Cardiovasc Pharmacol. 1989;13 Suppl 2:S50-2; discussion S52. doi: 10.1097/00005344-198900132-00010.
Abstract
摘要
相似文献
1
Factors influencing the lipid response to selective alpha 1-inhibition.影响脂质对选择性α1-抑制反应的因素。
J Cardiovasc Pharmacol. 1989;13 Suppl 2:S50-2; discussion S52. doi: 10.1097/00005344-198900132-00010.
2
Influence of doxazosin on lipid transport in rats and hamsters.
J Cardiovasc Pharmacol. 1989;13 Suppl 2:S31-6; discussions 36-7. doi: 10.1097/00005344-198900132-00007.
3
Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
J Cardiovasc Pharmacol. 1989;13 Suppl 2:S5-9; discussion S9-10. doi: 10.1097/00005344-198900132-00003.
4
Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.多沙唑嗪和普萘洛尔给药对高胆固醇喂养大鼠脂蛋白脂肪酶的影响。
J Cardiovasc Pharmacol. 1987;10 Suppl 9:S16-20.
5
Effects of doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdJ mouse.多沙唑嗪及其他抗高血压药物对C57BR/cdJ小鼠血脂水平和脂蛋白脂肪酶的影响。
J Cardiovasc Pharmacol. 1989;13 Suppl 2:S11-8; discussion S18-9. doi: 10.1097/00005344-198900132-00004.
6
Effects of the selective alpha 1-antagonist, doxazosin, on hepatic lipid levels and metabolism in the golden hamster.选择性α1拮抗剂多沙唑嗪对金黄地鼠肝脏脂质水平及代谢的影响。
J Cardiovasc Pharmacol. 1991 Sep;18(3):354-60. doi: 10.1097/00005344-199109000-00008.
7
Studies with doxazosin on the saturable binding of 125I-LDL by liver in normocholesterolemic mice.在正常胆固醇血症小鼠中，使用多沙唑嗪对肝脏中125I-LDL的饱和结合进行的研究。
J Cardiovasc Pharmacol. 1987;10 Suppl 9:S35-41.
8
Inhibition of hepatic cholesterol synthesis by the alpha 1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster.
Life Sci. 1989;44(15):1013-7. doi: 10.1016/0024-3205(89)90552-3.
9
Doxazosin increases low density lipoprotein receptor activity.多沙唑嗪可增加低密度脂蛋白受体活性。
Acta Pharmacol Toxicol (Copenh). 1985 Mar;56(3):269-72. doi: 10.1111/j.1600-0773.1985.tb01288.x.
10
Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.多沙唑嗪对饮食诱导的C57BR/cdJ小鼠高胆固醇血症的影响。
Am J Cardiol. 1987 May 29;59(14):29G-34G. doi: 10.1016/0002-9149(87)90154-8.
引用本文的文献
1
Clinical pharmacokinetics of vasodilators. Part II.血管扩张剂的临床药代动力学。第二部分。
Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002.
2
Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.多沙唑嗪。其临床药理学及在高血压和良性前列腺增生症治疗应用方面的最新进展。
Drugs. 1995 Feb;49(2):295-320. doi: 10.2165/00003495-199549020-00011.
Zotero 插件